ACON Injectable Investors I
Washington, US · Founded 2021 · Ontario, Canada limited partnership
Founders & leadership
MW
Masumi WaidaNamed on SEC filing
TY
Teresa Y. BernsteinNamed on SEC filing
Board
JK
Jose KnoellManaging Director of the General Partner of the Issuer.
Reported raises · per SEC filings
Form D private placements$59M disclosed across 1 round · 2021
▶$59MraisedJun 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$59MraisedJun 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Masumi WaidaExecutive Officer
- Teresa Y. BernsteinExecutive Officer
- ALAOF V GenPar, L.L.C.Promoter
- Jose KnoellExecutive Officer
- Offering amount
- $74M
- Amount sold
- $59M
- First sale
- May 2021
- Incorporated
- Limited Partnership, Ontario, Canada, 2021
- Federal exemptions
- 06b, 3C, 3C.7
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ACON Injectable Investors I raised?
- ACON Injectable Investors I has disclosed $59M raised across 1 round.
- Where is ACON Injectable Investors I headquartered?
- ACON Injectable Investors I is headquartered in Washington, US.